{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:44:12Z","timestamp":1775061852318,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016399","name":"Japan Osteoporosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoporosis and Sarcopenia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.afos.2026.02.002","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:19:31Z","timestamp":1772489971000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of genetic polymorphisms of aldehyde dehydrogenase 2 on the efficacy of intermittent parathyroid hormone treatment and bone mineral density: A retrospective multicenter study"],"prefix":"10.1016","volume":"12","author":[{"given":"Hinako","family":"Obara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7646-3461","authenticated-orcid":false,"given":"Takafumi","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9382-0849","authenticated-orcid":false,"given":"Yoshiaki","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6936-3019","authenticated-orcid":false,"given":"Hitoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumichi","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6023-5536","authenticated-orcid":false,"given":"Akinori","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.afos.2026.02.002_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1432-1327.1998.2510549.x","article-title":"Human aldehyde dehydrogenase gene family","volume":"251","author":"Yoshida","year":"1998","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.afos.2026.02.002_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/10715762.2013.864761","article-title":"Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease","volume":"48","author":"Mali","year":"2014","journal-title":"Free Radic Res"},{"key":"10.1016\/j.afos.2026.02.002_bib3","doi-asserted-by":"crossref","first-page":"15539","DOI":"10.1074\/jbc.R800001200","article-title":"Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation","volume":"283","author":"Schneider","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.afos.2026.02.002_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0021-9150(02)00059-X","article-title":"Genetic variation in aldehyde dehydrogenase 2 and the effect of alcohol consumption on cholesterol levels","volume":"164","author":"Nakamura","year":"2002","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.afos.2026.02.002_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1469-1809.2009.00517.x","article-title":"Refined geographic distribution of the oriental ALDH2\u2217504Lys (Nee 487Lys) variant","volume":"73","author":"Li","year":"2009","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.afos.2026.02.002_bib6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s00535-005-1610-3","article-title":"Esophageal melanosis, an endoscopic finding associated with squamous cell neoplasms of the upper aerodigestive tract, and inactive aldehyde dehydrogenase-2 in alcoholic Japanese men","volume":"40","author":"Yokoyama","year":"2005","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.afos.2026.02.002_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/bbrc.2000.2923","article-title":"Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population","volume":"273","author":"Kamino","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.afos.2026.02.002_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.atherosclerosis.2010.03.030","article-title":"The ALDH2 Glu504Lys polymorphism is associated with coronary artery disease in Han Chinese: relation with endothelial ADMA levels","volume":"211","author":"Guo","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.afos.2026.02.002_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031522","article-title":"Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease","volume":"7","author":"Wey","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.afos.2026.02.002_bib10","doi-asserted-by":"crossref","first-page":"13079","DOI":"10.1038\/s41598-018-31491-6","article-title":"Genetic polymorphisms of ALDH2 are associated with lumbar disc herniation in a Chinese Han population","volume":"8","author":"Dong","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.afos.2026.02.002_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41598-017-00503-2","article-title":"A missense single nucleotide polymorphism in the ALDH2 gene, rs671, is associated with hip fracture","volume":"7","author":"Takeshima","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.afos.2026.02.002_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00223-017-0285-0","article-title":"Disruption of the aldehyde dehydrogenase 2 gene results in no increase in trabecular bone mass due to skeletal loading in association with impaired cell cycle regulation through p21 expression in the bone marrow cells of mice","volume":"101","author":"Okuma","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.afos.2026.02.002_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bone.2018.02.020","article-title":"Cortical bone loss due to skeletal unloading in aldehyde dehydrogenase 2 gene knockout mice is associated with decreased PTH receptor expression in osteocytes","volume":"110","author":"Tajima","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.afos.2026.02.002_bib14","doi-asserted-by":"crossref","first-page":"115370","DOI":"10.1016\/j.bone.2020.115370","article-title":"Disruption of the aldehyde dehydrogenase 2 gene increases the bone anabolic response to intermittent PTH treatment in an ovariectomized mouse model","volume":"136","author":"Kosugi","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.afos.2026.02.002_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12929-016-0312-x","article-title":"Aldehyde dehydrogenase 2 activation and coevolution of its \u03b5PKC-mediated phosphorylation sites","volume":"24","author":"Nene","year":"2017","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.afos.2026.02.002_bib16","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3390\/ijms23052682","article-title":"Aldehyde dehydrogenase 2 as a therapeutic target in oxidative stress-related diseases: post-translational modifications deserve more attention","volume":"23","author":"Gao","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.afos.2026.02.002_bib17","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1007\/s12012-024-09923-9","article-title":"Advances in factors affecting ALDH2 activity and its mechanisms","volume":"24","author":"Liu","year":"2024","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.afos.2026.02.002_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1302\/2046-3758.71.BJR-2016-0242.R2","article-title":"Parathyroid hormone-related protein exhibits antioxidant features in osteoblastic cells through its N-terminal and osteostatin domains","volume":"7","author":"Portal-N\u00fa\u00f1ez","year":"2018","journal-title":"Bone Joint Res"},{"key":"10.1016\/j.afos.2026.02.002_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00017.2013","article-title":"Targeting aldehyde dehydrogenase 2: new therapeutic opportunities","volume":"94","author":"Chen","year":"2014","journal-title":"Physiol Rev"},{"key":"10.1016\/j.afos.2026.02.002_bib20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2217\/pgs.14.12","article-title":"LRP5 polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis","volume":"15","author":"Zhou","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.afos.2026.02.002_bib21","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2217\/pgs.15.76","article-title":"SOST polymorphisms and response to alendronate treatment in postmenopausal Chinese women with osteoporosis","volume":"16","author":"Zhou","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.afos.2026.02.002_bib22","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00198-004-1800-5","article-title":"BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial","volume":"16","author":"Palomba","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2026.02.002_bib23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/humrep\/deg031","article-title":"Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes","volume":"18","author":"Palomba","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.afos.2026.02.002_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bone.2010.05.022","article-title":"Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases","volume":"47","author":"Miyauchi","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.afos.2026.02.002_bib25","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1080\/03007995.2017.1354826","article-title":"Real-world effectiveness of daily teriparatide in Japanese patients with osteoporosis at high risk for fracture: final results from the 24-month Japan fracture observational study (JFOS)","volume":"33","author":"Soen","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.afos.2026.02.002_bib26","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1210\/jc.2011-3479","article-title":"Randomized teriparatide [Human parathyroid hormone (PTH) 1-34] once-weekly efficacy research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk","volume":"97","author":"Nakamura","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2026.02.002_bib27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00774-011-0314-4","article-title":"Effects of teriparatide in Japanese and Non-Japanese populations: bridging findings on pharmacokinetics and efficacy","volume":"30","author":"Tsujimoto","year":"2012","journal-title":"J Bone Miner Metabol"},{"key":"10.1016\/j.afos.2026.02.002_bib28","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049601","article-title":"ALDH2 variance in disease and populations","volume":"15","author":"Chen","year":"2022","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.afos.2026.02.002_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00198-013-2426-2","article-title":"An algorithm using the early changes in PINP to predict the future BMD response for patients treated with daily teriparatide","volume":"25","author":"Niimi","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2026.02.002_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1620\/tjem.239.17","article-title":"Bisphosphonate pre-treatment diminishes the therapeutic benefits of teriparatide in Japanese osteoporotic patients","volume":"239","author":"Kamimura","year":"2016","journal-title":"Tohoku J Exp Med"}],"container-title":["Osteoporosis and Sarcopenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240552552600004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240552552600004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:01:03Z","timestamp":1775055663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240552552600004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S240552552600004X"],"URL":"https:\/\/doi.org\/10.1016\/j.afos.2026.02.002","relation":{},"ISSN":["2405-5255"],"issn-type":[{"value":"2405-5255","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of genetic polymorphisms of aldehyde dehydrogenase 2 on the efficacy of intermittent parathyroid hormone treatment and bone mineral density: A retrospective multicenter study","name":"articletitle","label":"Article Title"},{"value":"Osteoporosis and Sarcopenia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.afos.2026.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}